.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recent research identifies serglycin as a major driver of LAG3+ Treg differentiation in gastric cancer. This tumor-derived proteoglycan facilitates immune evasion by manipulating the microenvironment. Specifically, it acts through the CD44 receptor, which regulatory T cells (Tregs) express at high levels. By targeting this signaling axis, clinicians might eventually improve the effectiveness of existing cancer treatments.
Furthermore, analysis of single-cell RNA-sequencing data confirms that serglycin levels correlate significantly with Treg enrichment. Mechanistically, serglycin activates the CD44/TGFβRI/Smad3 signaling pathway. Consequently, this activation promotes cellular glycolysis while facilitating the clearance of reactive oxygen species (ROS). Therefore, these metabolic changes are crucial for stabilizing the LAG3 protein within the immunosuppressive tumor microenvironment.
Specifically, the reduction in cellular oxidation attenuates the M171 modification of LAG3. This change enhances LAG3 dimerization and disrupts its interaction with the ubiquitin ligase PELI1. As a result, LAG3 avoids K48-linked ubiquitination and subsequent degradation. Moreover, these findings suggest that the metabolic state of the T cell directly controls the stability of its inhibitory receptors.
Collectively, these findings identify a serglycin-CD44-mediated metabolic cascade that functions as a critical driver of LAG3+ Treg differentiation. Blocking this pathway in pre-clinical models has successfully relieved immunosuppression and inhibited tumor progression. Therefore, targeting this axis offers a promising strategy for enhancing immunotherapy. For instance, combining serglycin inhibitors with LAG3 blockades might yield superior results in patients with gastric malignancies.
Serglycin is a proteoglycan secreted by gastric cancer cells. It binds to the CD44 receptor on regulatory T cells to promote their differentiation and maintain their suppressive functions, allowing the tumor to evade the immune system.
This axis triggers metabolic changes, including increased glycolysis and ROS clearance. This environment prevents the oxidative modification of LAG3 at the M171 residue, which prevents its degradation and leads to increased LAG3 protein levels on Tregs.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. It is not intended to be a substitute for professional medical judgment, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Wang Q et al. Serglycin Drives LAG3+ Treg Differentiation and Immunosuppression in Gastric Cancer. Cancer Res. 2026 Feb 24. doi: 10.1158/0008-5472.CAN-25-3071. PMID: 41734377.
Li X, et al. The role of CD44 in the tumor immune microenvironment. J Hematol Oncol. 2023.
Zhang Y, et al. LAG3 as a target in cancer immunotherapy. Front Immunol. 2024.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Study identifies a serglycin-CD44-LAG3 axis that drives immunosuppressive Treg differentiation in gastric cancer, offering new targets for immunotherapy....
5 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
